Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes

Last updated: August 17, 2026

Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes
Date:
December 2, 2021
Source:
Cell Press
Summary:
Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 diabetes. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human pluripotent stem cells (PSCs), were tested in 26 patients. While the insulin secreted by the implants did not have clinical effects in the patients, the data are the first reported evidence of meal-regulated insulin secretion by differentiated stem cells in human patients.

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

• Review of the information you provide
• Relevant research and clinical program information
• A clear response focused on your situation

What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.

Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

☎ WhatsApp Request My Personal Scientific Review ✉ Email Request My Personal Scientific Review

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.